Bendamustin bei B-Zell-Neoplasien und kleinzelligen Bronchialkarzinomen

Publisher： Karger

E-ISSN： 2296-5262|26|5|512-512

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.5, 2003-11, pp. : 512-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aktuelle und künftige Indikationen mit Bendamustin: chronische lymphatische Leukämie, indolente Lymphome, Mantelzell-Lymphome und diffuse großzellige B-Zell-Lymphome

By  

Oncology Research and Treatment, Vol. 36, Iss. 1, 2013-01 ,pp. : 11-18

Karger

Access to resources Recommend Favorite

Bendamustin. Neue Wege bei Lymphomen und soliden Tumoren. Bendamustin-Workshop, Dresden, 2. September 2000

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Aktive Immuntherapie bei Patienten mit hämatologischen und soliden Neoplasien

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 4-8

Karger

Access to resources Recommend Favorite

Kutane B-Zell-Lymphome: Klassifikation und Diagnostik

By Geissinger E.   Adam P.   Müller-Hermelink H.K.   Rüdiger T.  

Der Pathologe, Vol. 28, Iss. 1, 2007-02 ,pp. : 15-20

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenese bei hämatologischen Neoplasien

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2004-11 ,pp. : 75-80

Karger

Access to resources Recommend Favorite